Global Human Milk Oligosaccharides (HMO) Market Growth 2023-2029

Global Human Milk Oligosaccharides (HMO) Market Growth 2023-2029

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
LPI (LP Information)' newest research report, the “Human Milk Oligosaccharides (HMO) Industry Forecast” looks at past sales and reviews total world Human Milk Oligosaccharides (HMO) sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Milk Oligosaccharides (HMO) sales for 2023 through 2029. With Human Milk Oligosaccharides (HMO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Milk Oligosaccharides (HMO) industry.
This Insight Report provides a comprehensive analysis of the global Human Milk Oligosaccharides (HMO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Milk Oligosaccharides (HMO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Milk Oligosaccharides (HMO) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Milk Oligosaccharides (HMO) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Milk Oligosaccharides (HMO).
The global Human Milk Oligosaccharides (HMO) market size is projected to grow from US$ 376.5 million in 2022 to US$ 1039.5 million in 2029; it is expected to grow at a CAGR of 1039.5 from 2023 to 2029.
Global core human milk oligosaccharides (HMO) manufacturers include Abbott, Glycom etc.The top 2 companies hold a share about 70%. North America is the largest market, with a share about 45%, followed by Europe and China with the share about 32% and 10%.In terms of product, 2'-FL & 3-FL is the largest segment, with a share over 95%. And in terms of application, the largest application is infant formula.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Milk Oligosaccharides (HMO) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
Segmentation by application
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
ZuChem
Glycom
Key Questions Addressed in this Report
What is the 10-year outlook for the global Human Milk Oligosaccharides (HMO) market?
What factors are driving Human Milk Oligosaccharides (HMO) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Milk Oligosaccharides (HMO) market opportunities vary by end market size?
How does Human Milk Oligosaccharides (HMO) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.